このページの翻訳は実験的なもので、現在開発中です。お待ちしております
China Shineway Pharmaceutical Group バランスシートの健全性
財務の健全性 基準チェック /56
China Shineway Pharmaceutical Groupの総株主資本はCN¥7.0B 、総負債はCN¥300.0Mで、負債比率は4.3%となります。総資産と総負債はそれぞれCN¥9.6BとCN¥2.5Bです。 China Shineway Pharmaceutical Groupの EBIT はCN¥970.1Mで、利息カバレッジ比率-9.4です。現金および短期投資はCN¥5.9Bです。
主要情報
4.5%
負債資本比率
CN¥330.00m
負債
| インタレスト・カバレッジ・レシオ | -5.7x |
| 現金 | CN¥6.23b |
| エクイティ | CN¥7.34b |
| 負債合計 | CN¥2.55b |
| 総資産 | CN¥9.88b |
財務の健全性に関する最新情報
Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13
China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10
Recent updates
If EPS Growth Is Important To You, China Shineway Pharmaceutical Group (HKG:2877) Presents An Opportunity
Jun 03Is China Shineway Pharmaceutical Group (HKG:2877) A Risky Investment?
May 13China Shineway Pharmaceutical Group (HKG:2877) Has Announced That It Will Be Increasing Its Dividend To CN¥0.461
Apr 26Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 41%?
Apr 17China Shineway Pharmaceutical Group (HKG:2877) Is Increasing Its Dividend To CN¥0.461
Mar 31China Shineway Pharmaceutical Group Limited's (HKG:2877) 26% Price Boost Is Out Of Tune With Earnings
Mar 14Does China Shineway Pharmaceutical Group (HKG:2877) Deserve A Spot On Your Watchlist?
Jan 29China Shineway Pharmaceutical Group (HKG:2877) Seems To Use Debt Rather Sparingly
Sep 28China Shineway Pharmaceutical Group (HKG:2877) Is Paying Out A Dividend Of CN¥0.118
Sep 01We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Aug 03Are Investors Undervaluing China Shineway Pharmaceutical Group Limited (HKG:2877) By 44%?
May 30We Ran A Stock Scan For Earnings Growth And China Shineway Pharmaceutical Group (HKG:2877) Passed With Ease
Mar 07China Shineway Pharmaceutical Group's (HKG:2877) Dividend Will Be Reduced To CN¥0.125
Sep 01China Shineway Pharmaceutical Group Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 31China Shineway Pharmaceutical Group (HKG:2877) Has A Rock Solid Balance Sheet
Apr 07China Shineway Pharmaceutical Group's(HKG:2877) Share Price Is Down 55% Over The Past Three Years.
Mar 11Should You Buy China Shineway Pharmaceutical Group Limited (HKG:2877) For Its Dividend?
Feb 18Should You Use China Shineway Pharmaceutical Group's (HKG:2877) Statutory Earnings To Analyse It?
Jan 31Is China Shineway Pharmaceutical Group Limited (HKG:2877) Trading At A 49% Discount?
Jan 13What Is The Ownership Structure Like For China Shineway Pharmaceutical Group Limited (HKG:2877)?
Dec 25We Think China Shineway Pharmaceutical Group (HKG:2877) Can Manage Its Debt With Ease
Dec 10Reflecting on China Shineway Pharmaceutical Group's (HKG:2877) Share Price Returns Over The Last Five Years
Nov 25財務状況分析
短期負債: 2877の 短期資産 ( CN¥8.2B ) が 短期負債 ( CN¥2.4B ) を超えています。
長期負債: 2877の短期資産 ( CN¥8.2B ) が 長期負債 ( CN¥105.5M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: 2877総負債よりも多くの現金を保有しています。
負債の削減: 2877の負債対資本比率は、過去 5 年間で0%から4.3%に増加しました。
債務返済能力: 2877の負債は 営業キャッシュフロー によって 十分にカバー されています ( 310.9% )。
インタレストカバレッジ: 2877支払う利息よりも稼ぐ利息の方が多いので、利息支払い の補償は問題になりません。